View abstract

Cet abstract a été assigné à session AOB and FRO E-Posters

Titre	Introducing Ruthenium Brachytherapy in UZ Leuven
Abstract Nr.	3015

But	To introduce Ruthenium Brachytherapy at the UZ Leuven hospitals to improve the local treatment of uveal and conjunctival ocular tumors.
Méthodes	Ruthenium brachytherapy has been used for 3 decades now in European ocular oncology centers, to treat small and middle sized melanomas. Building on these experiences, we introduce this state-of-the-art treatment with local recurrence of 5% and limited radiation retinopathy.
Résultats	The implications for treatment of Ruthenium brachytherapy, with a longer hospital stay than Strontium brachytherapy, follow-up, and safety protocols will be discussed in the presentation.
Conclusion	Introducing Ruthenium brachytherapy in Belgium for the treatment of ocular tumors, expands the range of tumors that can be treated locally, with a minimum of complications.
Conflit d'intérêt	Non

Auteur 1

Nom	MISSOTTEN
Initiales	G
Institut	Dept Ophthalmology, Catholic University Leuven
Ville	Leuven

Auteur 2

Nom	Van Ginderdeuren
Initiales	R
Institut	Dept Ophthalmology, Catholic University Leuven
Ville	Leuven

Auteur 3

Nom	Clément
Initiales	P
Institut	Dept Medical Oncology, Catholic University Leuven
Ville	Leuven

Auteur 4

Nom	Vanden Bempt
Initiales	I
Institut	Dept Medical Genetics, Catholic University Leuven
Ville	Leuven

Auteur 5

Nom	Van Limbergen
Initiales	E
Institut	Dept Radiotherapy, Catholic University Leuven
Ville	Leuven

Auteur 6

Nom	Van Calster
Initiales	J
Institut	Dept Ophthalmology, Catholic University Leuven
Ville	Leuven